Hanmi Pharm to dispose treasury shares for incentives
한미약품
128940
Signal Score
Historical Avg Return (5d)
+0.03%
Data Coverage
60%n=180
Risk-adjusted indicator based on 180 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Total Disposal Shares: 10,402 Shares (Common Stock)
- • Disposal Value (estimated): 4,062,991,000 KRW
- • Disposal Price per Share: 390,500 KRW
- • Disposal Ratio to Total Outstanding Shares: 0.08%
- • Number of Employees Receiving PI (RSA): 644 employees
- • Number of Employees Receiving RSU: 18 employees
AI Analysis Summary
Hanmi Pharm. Co., Ltd. has decided to dispose of 10,402 common shares from its treasury stock, valued at an estimated 4,062,991,000 KRW based on the July 27, 2026 closing price of 390,500 KRW per share. The disposal, representing 0.08% of total outstanding shares (12,810,991 shares), is for employee incentives (7,562 shares for 644 employees as PI/RSA and 2,840 shares for 18 employees as RSU). The company expects limited stock dilution. The actual number of shares and disposal amount may change based on performance evaluations and market prices at the time of disposal. The impact is largely neutral as it's for employee compensation, with minimal dilution.
How This Event Is Evaluated
Treasury Share Disposal Evaluation
Treasury share disposal events are evaluated by assessing supply impact, disposal method, and stated purpose.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Disposal size relative to shares outstanding
- Disposal method and timing
- Stated purpose (funding, compensation, etc.)
- Dilution / supply impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.